Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2015

October 24, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 23, 2014 /PRNewswire/ –ResMed Inc. (NYSE: RMD) today announced results for its quarter ended September 30, 2014. Revenue for the quarter was $380.4 million, a 6 percent increase compared to the quarter ended September…

La Jolla Pharmaceutical Company Announces Data Presentation At The American Society of Nephrology Kidney Week

October 24, 2014 – 5:00 am | Edit Post

La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that an abstract of the results for the Companys Phase 2 clinical trial of GCS-100 in chronic kidney disease (CKD) has been selected by the American Society…

BiCOM Announces 2014 Elected Official Of The Year

October 24, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 23, 2014 /PRNewswire/ — Biocom, the association for the Southern California life science community, today announced that Congressman Scott Peters (D-52) will be honored as Biocom’s 2014 Elected Official of the Year at the Biocom Celebration…

Imprimis Pharmaceuticals Reports On Positive Clinical Findings Presented At The American Academy of Ophthalmology Annual Meeting

October 24, 2014 – 5:00 am | Edit Post

Imprimis Pharmaceuticals Reports on Positive Clinical Findings Presented at the American Academy of Ophthalmology (AAO) Annual MeetingSAN DIEGO, Oct. 24, 2014 /PRNewswire/ –Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a specialty pharmaceutical company focused on the development…

Stellar Biotechnologies, Inc. And Biovest International, Inc. Sign KLH Supply Agreement For BiovaxID Immunotherapy For Follicular Non-Hodgkin’s Lymphoma

October 24, 2014 – 5:00 am | Edit Post

PORT HUENEME, CA–(Marketwired – October 23, 2014) – Highlighted Links Stellar Biotechnologies Website 

BIOCOM Announces 2014 Elected Official Of The Year

October 24, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 23, 2014 /PRNewswire/ — Biocom, the association for the Southern California life science community, today announced that Congressman Scott Peters (D-52) will be honored as Biocom’s 2014 Elected Official of the Year at the Biocom Celebration…

Tug-Of-War Over Revlimid Patent Continues Between Celgene, Natco Pharma Limited

October 24, 2014 – 5:00 am | Edit Post

UC San Diego Named Stem Cell “Alpha Clinic”

October 23, 2014 – 3:56 pm | Edit Post

In a push to further speed clinical development of emerging stem cell therapies, Sanford Stem Cell Clinical Center at UC San Diego Health System was named today one of three new “alpha clinics” by the California Institute for Regenerative Medicine, the state’s stem cell agency.

West Coast Biotech Roundup: Genentech, Sutro, Amgen, Regulus & More

October 23, 2014 – 3:06 pm | Edit Post

Immunotherapy deals that could reach $1 billion? We’ve got two of them this week. Sure, those billion-dollar figures include, as they often do, a lot of biobucks, but the rest of the details in…
[[Click headline to continue reading.]]

UCSD, other stem cell clinics get millions

October 23, 2014 – 1:45 pm | Edit Post

UC San Diego, UC Los Angeles and City of Hope receive $8 million each from state agency.